Optimi Health Up 7.8% as After Health Canada Go-Ahead to Supply MDMA and Psilocybin to Patients in Australia

Optimi Health (OPTI.CN) on Tuesday said it received three export permits from Health Canada to supply MDMA and psilocybin capsules for use in patients participating in Australia's Authorised Prescrib

MT NewswiresJun 25 23:30

Optimi Health Up 12% After Reporting Drug Establishment License From Health Canada

Optimi Health (OPTI.CN), a licensed psychedelics pharmaceutical manufacturer specializing in controlled substances, was last seen up 12% after the company on Monday said Health Canada awarded the comp

MT NewswiresJun 4 02:07

Optimi Health to Be Sole Supplier of Psilocybin for ATMA Journey Centers Phase II Trial

Optimi Health (OPTI.CN) signed a letter of intent to supply its GMP natural psilocybin extract for ATMA Journey Center's Phase II Psilocybin Clinical Trial. The companies will finalize a definitive ag

MT NewswiresMay 22 21:41

Optimi Health Notes Lykos Therapeutics and FDA Priority Review of New Drug Application

Optimi Health Corp. (OPTI.CN), a Health Canada licensed drug researcher and formulator specializing in controlled psychedelic substances such as natural psilocybin and MDMA, and a company that saw its

MT NewswiresFeb 12 21:00

Optimi Health Secures Amendment to Increase Quantities of MDMA, MDA, and 2C-B

Optimi Health Corp. (OPTI.CN), specializing in controlled psychedelic substances such as natural psilocybin and MDMA, on Friday said it has been granted an amendment to its Health Canada Controlled Dr

MT NewswiresJan 19 20:56

Optimi Health Seek Regulatory Nod for Initial Testing of Psychedelic Drug Combination

12:05 PM EST, 02/07/2023 (MT Newswires) -- Optimi Health (OPTI.CSE) was higher Tuesday after the drug maker said it has filed documentation with Canadian authorities for an early-stage study to evalua

MT NewswiresFeb 8, 2023 01:09